Optimization of an HPLC method for determination of gabapentin in dosage forms through derivatization with 1-fluoro-2,4-dinitrobenzene

Chemical and Pharmaceutical Bulletin

Volumn 55, Issue 10, 2007, Pages 1427-1430

  Souri, Effat ^a   Jalalizadeh, Hassan ^a   Shafiee, Abbas ^a  

^a Tehran University of Medical Sciences   (Iran)

Author keywords

1 fluoro 2; 4 dinitrobenzene; Dosage form; Gabapentin; HPLC; Uv detection

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; AMLODIPINE; GABAPENTIN;

ARTICLE; DERIVATIZATION; DRUG CAPSULE; DRUG DETERMINATION; DRUG QUALITY; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SEPARATION TECHNIQUE; TECHNIQUE; ULTRAVIOLET RADIATION;

AMINES; ANTICONVULSANTS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOHEXANECARBOXYLIC ACIDS; DINITROFLUOROBENZENE; DOSAGE FORMS; GAMMA-AMINOBUTYRIC ACID; HUMANS; HYDROGEN-ION CONCENTRATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 35648981570     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.55.1427     Document Type: Article

References (22)

1. Tallian K. B., Nahata M. C., Lo W., Tsao C. Y., J. Clin. Pharm. Ther., 29, 511-515 (2004).
2. Taylor C. P., Angelotti T., Fauman E., Epilepsy Res., 73, 137-150 (2007).
3. Hengy H., Kolle E. U., J. Chromatogr. B, 341, 473-478 (1985).
4. Juenke J. M., Brown P. I., McMillin G. A., Urry F. M., Clin. Chem., 49, 1198-1201 (2003).
5. Zhu Z., L. Neirinck L., J. Chromatogr. B, 779, 307-312 (2002).
6. Forrest G., Sills G. L., Leach J. P., Brodie M. J., J. Chromatogr. B, 681, 421-425 (1996).
7. Ratnaraj H., Patsalos P. N., Ther. Drug Monit., 20, 430-434 (1998).
8. Jiang Q., Li S., J. Chromatogr. B, 727, 119-123 (1999).
9. Tang P. H., Miles M. V., Glauser T. A., De Grauw T., J. Chromatogr. B, 727, 125-129 (1999).
10. Chollet D. F., Goumaz L., Juliano C., Anderegg G., J. Chromatogr. B, 746, 311-314 (2000).
11. Gauthier J. D., Gupta R., Clin. Chem., 48, 2259-2261 (2002).
12. Vermeij T. A. C., Edelbroek P. M., J. Chromatogr. B, 810, 297-303 (2004).
13. Bahrami Gh., Mohammadi B., J. Chromatogr. B, 837, 24-28 (2006).
14. Bahrami Gh., Kiani A., J. Chromatogr. B, 835, 123-126 (2006).
15. Sagirli O., Cetin S. M., Onal A., J. Pharm. Biomed. Anal., 42, 618-624 (2006).
16. "The United States Pharmacopeia," 30th revision, Asian Edition, United States Pharmacopeial Convention, Inc., Twinbrook Parkway, Rockville, MD, 2007, p. 2200.
17. Belal F., Abdine H., Al-Majed A., Khalil N. Y., J. Pharm. Biomed. Anal., 27, 253-260 (2002).
18. Abdellatef H. E., Khalil H. M., J. Pharm. Biomed. Anal., 31, 209-214 (2003).
19. Sekar R., Azhaguvel S., J. Pharm. Biomed. Anal., 36, 663-667 (2004).
20. Zhou M., Wei G., Liu Y., Sun Y., Xiao Sh., Lu L., Liu Ch., Zhong D., J. Chromatogr. B, 798, 43-48 (2003).
21. Nicoli S., Santi P., J. Pharm. Biomed. Anal., 41, 994-997 (2006).
22. Paraskevas G., Atta-Politou J., Koupparis M., J. Pharm. Biomed. Anal., 29, 865-872 (2002).